Clover Health Investments Corp (NASDAQ: CLOV) is 123.88% higher on its value in year-to-date trading and has touched a low of $1.45 and a high of $4.87 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CLOV stock was last observed hovering at around $2.92 in the last trading session, with the day’s gains setting it 0.08%.
Currently trading at $3.0, the stock is 4.61% and -3.89% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 6.41 million and changing 2.74% at the moment leaves the stock -15.95% off its SMA200. CLOV registered -4.76% loss for a year compared to 6-month loss of -17.58%. The firm has a 50-day simple moving average (SMA 50) of $3.1214 and a 200-day simple moving average (SMA200) of $3.5691.
The stock witnessed a 1.01% gain in the last 1 month and extending the period to 3 months gives it a -18.26%, and is 3.81% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.51% over the week and 5.55% over the month.
Clover Health Investments Corp (CLOV) has around 570 employees, a market worth around $1.53B and $1.49B in sales. Profit margin for the company is -1.69%. Distance from 52-week low is 106.90% and -38.40% from its 52-week high. The company has generated returns on investments over the last 12 months (-7.47%).
The EPS is expected to grow by 36.85% this year.
Clover Health Investments Corp (CLOV) Top Institutional Holders
244.0 institutions hold shares in Clover Health Investments Corp (CLOV), with institutional investors hold 27.22% of the company’s shares. The shares outstanding are 388.51M, and float is at 382.46M with Short Float at 11.00%. Institutions hold 26.16% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 17.35 million shares valued at $21.33 million. The investor’s holdings represent 3.5581% of the CLOV Shares outstanding. As of 2024-06-30, the second largest holder is RENAISSANCE TECHNOLOGIES LLC with 11.27 million shares valued at $13.86 million to account for 2.3123 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 9.54 million shares representing 1.9568% and valued at over $11.73 million, while PNC FINANCIAL SERVICES GROUP, INC. holds 1.0279 of the shares totaling 5.01 million with a market value of $6.16 million.
Clover Health Investments Corp (CLOV) Insider Activity
The most recent transaction is an insider sale by Reynoso Jamie L., the company’s CEO, Medicare Advantage. SEC filings show that Reynoso Jamie L. sold 19,789 shares of the company’s common stock on Jul 03 ’25 at a price of $2.58 per share for a total of $51056.0. Following the sale, the insider now owns 3.31 million shares.
Clover Health Investments Corp disclosed in a document filed with the SEC on Jul 07 ’25 that Reynoso Jamie L. (CEO, Medicare Advantage) sold a total of 2,012 shares of the company’s common stock. The trade occurred on Jul 07 ’25 and was made at $2.85 per share for $5734.0. Following the transaction, the insider now directly holds 3.3 million shares of the CLOV stock.
